In the quest to comprehend the origins and mysteries of schizophrenia, a groundbreaking study led by Harvard Medical School clinician-scientist Eduardo Maury has uncovered genetic deletions associated with the disorder that likely occur during early gestation.
This discovery, based on an extensive analysis of genetic data from nearly 25,000 individuals with and without schizophrenia, adds a new dimension to the understanding of this complex neurological disorder.
Schizophrenia, affecting 1 in 300 people worldwide, typically manifests in early adulthood. The prevailing belief has been that genetic and environmental factors, such as childhood trauma or viral infections, contribute to an individual’s risk of developing the disorder.
However, recent research suggests that the physiological roots of schizophrenia may be established either in early pregnancy or due to gestational complications.
Maury and his team focused on two genes, NRXN1 and ABCB11, both exhibiting copy number variations—genetic errors involving the duplication or deletion of gene copies. Importantly, these alterations were found in utero and were not inherited from parents, challenging the conventional understanding that most cases of schizophrenia are linked to inherited genetic mutations.
NRXN1, a gene associated with brain cell signal transmission, has been implicated in schizophrenia when mutations are inherited. However, Maury’s team identified partial deletions of NRXN1 in five cases of schizophrenia, a prevalence significantly higher than in population-level databases. Notably, these deletions were not present in unaffected individuals in the control cohort.
Mysteries of Schizophrenia And Somatic Mutation
The discovery of somatic mutations—genetic changes acquired during early development or later in life—in NRXN1 challenges previous assumptions about the genetic basis of schizophrenia.
Somatic mutations, unlike germline mutations inherited from parents, are found only in a fraction of body cells, such as brain and blood cells, but not in sex cells. This raises intriguing questions about the transmission and heritability of such mutations.
The second gene, ABCB11, encodes a liver protein, and its link to schizophrenia was less certain. Nevertheless, Maury and his team found deletions within the ABCB11 gene in five cases of schizophrenia, all of whom were unresponsive to antipsychotic medications. The unexpected association with treatment-resistant schizophrenia adds a layer of complexity to our understanding of this gene’s role in the disorder.
Eduardo Maury, and Chris Walsh, a senior author, and geneticist at Boston Children’s Hospital, stressed that further research is essential to quantify the contribution of these genetic alterations to the overall genetic architecture of schizophrenia.
While the study suggests that alterations in NRXN1 and ABCB11 may play a small but significant role, the intricacies of their impact and potential therapeutic implications require additional investigation.
The findings from this study present an opportunity for a paradigm shift in schizophrenia research, opening the door to early prevention strategies. If the seeds of schizophrenia are indeed planted in early gestation, as this research suggests, it could reshape our approach to identifying and addressing risk factors before the disorder fully manifests.
As the scientific community continues to unravel the mysteries of schizophrenia, this study encourages a more nuanced understanding of the interplay between genetics and the developmental timeline of this complex neurological disorder.
With each discovery, researchers inch closer to the possibility of early interventions that could change the trajectory for individuals at risk of schizophrenia, offering hope for improved outcomes and a deeper comprehension of the intricate puzzle that is schizophrenia.
Leave a Reply